Unknown

Dataset Information

0

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.


ABSTRACT:

SUBMITTER: Faivre-Finn C 

PROVIDER: S-EPMC5555437 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3282675 | biostudies-literature
| S-EPMC5318624 | biostudies-literature
| S-EPMC5210237 | biostudies-literature
| S-EPMC6217915 | biostudies-literature